首页> 外文期刊>Clinics and research in hepatology and gastroenterology >Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage - A case-control study
【24h】

Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage - A case-control study

机译:阿司匹林和非甾体类抗炎药是否会增加括约肌切开术后出血的风险-病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objective: Non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin have antiaggregant properties and patients with pancreaticobiliary disease commonly use these drugs. We prospectively investigated whether aspirin and NSAIDs are associated with endoscopic sphincterotomy related hemorrhage. Methods: Three hundred and eight patients who underwent sphincterotomy were sequentially recruited into this prospective case-control study. Pre-endoscopic assessment included a complete blood count, coagulation studies and a detailed drug history after sphincterotomy patients were followed up for bleeding. Cases and controls were compared for patient and procedure-related risk factors of post-endoscopic sphincterotomy bleeding. Results: Hemorrhage occured in 74 (24%) patients. Eight (2.6%) were clinically significant and five (1.6%) were severe. Amongst cases with hemorrhage, 17.6% were on NSAIDs and 14.9% on aspirin; 27.4% of controls took NSAIDs, and 9.8% aspirin (P> 0.05). Aspirin use in patients with significant (12.5%) or severe hemorrhage (20%) was not different from the controls (P> 0.05) and none of them had NSAIDs prior to sphincterotomy. Based on univariate analysis, coagulopathy and comorbidity were risk factors for significant post-sphincterotomy hemorrhage and coagulopathy was the only independent parameter (odds ratio = 22.72, 95% CI [4.25; 125]). Conclusion: Aspirin and NSAIDs do not increase the risk of post-sphincterotomy hemorrhage and they can be safely used before the procedure.
机译:背景与目的:非甾体类抗炎药(NSAIDs)和阿司匹林具有抗凝集作用,胰腺胆道疾病患者通常使用这些药物。我们前瞻性研究了阿司匹林和非甾体抗炎药是否与内镜括约肌切开术相关的出血有关。方法:308例接受括约肌切开术的患者被依次纳入这项前瞻性病例对照研究。内镜前评估包括全血细胞计数,凝血研究和括约肌切开术患者出血后的详细用药史。比较病例和对照的内镜下括约肌切开术出血患者和手术相关危险因素。结果:74(24%)位患者发生了出血。 8例(2.6%)有临床意义,5例(1.6%)严重。在出血病例中,非甾体抗炎药占17.6%,阿司匹林占14.9%。对照组中有27.4%的人服用了非甾体类抗炎药,而阿司匹林的使用率为9.8%(P> 0.05)。在有严重出血(12.5%)或严重出血(20%)的患者中使用阿司匹林与对照组无差异(P> 0.05),在括约肌切开术前均未使用过NSAID。根据单因素分析,凝血功能障碍和合并症是括约肌切开术后出血的重要危险因素,而凝血功能障碍是唯一的独立参数(赔率= 22.72,95%CI [4.25; 125])。结论:阿司匹林和非甾体抗炎药不会增加括约肌切开术后出血的风险,可以在手术前安全使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号